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Abstract: Introduction: Intraindividual variability (IIV) in motor performance
has been shown to predict future cognitive decline. The apolipoprotein Eepsilon 4 (APOE-ε4) allele is also a well-established risk factor for memory
decline. Here, we present novel findings examining the influence of the APOEε4 allele on the performance of asymptomatic healthy elders in comparison to
individuals with amnestic MCI (aMCI) on a fine motor synchronization, paced
finger-tapping task (PFTT). Method: Two Alzheimer’s disease (AD) risk
groups, individuals with aMCI (n = 24) and cognitively intact APOE-ε4 carriers
(n = 41), and a control group consisting of cognitively intact APOE-ε4 noncarriers (n = 65), completed the Rey Auditory Verbal Learning Test and the
PFTT, which requires index finger tapping in synchrony with a visual stimulus
(inter-stimulus interval = 333 milliseconds). Results: Motor timing IIV, as
reflected by the standard deviation of the inter-tap interval (ITI), was greater
in the aMCI group relative to the two groups of cognitively intact elders; in
contrast, all three groups had statistically equivalent mean ITI. No significant
IIV differences were observed between the asymptomatic APOE-ε4 carriers
and non-carriers. Poorer episodic memory performance was associated with
greater IIV, particularly in the aMCI group. Conclusions: Results suggest that
increased IIV on a fine motor synchronization task is apparent in aMCI. This
IIV measure was not sensitive in discriminating older asymptomatic
individuals at genetic risk for AD from those without such a genetic risk. In
contrast, episodic memory performance, a well-established predictor of
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cognitive decline in preclinical AD, was able to distinguish between the two
cognitively intact groups based on genetic risk.
Keywords: intraindividual variability, apolipoprotein ε4, motor timing,
episodic memory, aging, mild cognitive impairment

Introduction
The increased incidence of the apolipoprotein E-epsilon 4
(APOE-ε4) allele in mild cognitive impairment (MCI) and Alzheimer’s
disease (AD) is well established (Caselli et al., 2007; Corder et al.,
1993). There is also evidence that the presence of an APOE-ε4 allele is
a risk factor for conversion to MCI and AD in healthy older adults (see
Small, Rosnick, Fratiglioni, & Backman, 2004; Wisdom, Callahan, &
Hawkins, 2011 for reviews). As a result, there is considerable interest
in identifying reliable cognitive markers that discriminate APOE-ε4
carriers from non-carriers during the preclinical stage. Episodic
memory, executive functions, and attention are the most frequent
domains studied (Bondi, Salmon, Galasko, Thomas, & Thal, 1999;
Bookheimer et al., 2000; Rosen, Bergeson, Putnam, Harwell, &
Sunderland, 2002; Small et al., 2000).
These previous studies almost exclusively compared mean
scores between APOE-ε4 carriers and non-carriers. More recently,
there has been considerable interest in the possibility that
intraindividual variability (IIV) in task performance may be informative
in examining cognitive functioning in older adults. Support for this
notion is derived from studies showing that older adults exhibit greater
fluctuations in cognitive performance and greater variability in reaction
time (RT) tasks compared to younger adults (Bunce, MacDonald, &
Hultsch, 2004; Hilborn, Strauss, Hultsch, & Hunter, 2009; Hultsch,
MacDonald, & Dixon, 2002). For example, Hultsch, MacDonald, and
Dixon (2002) observed greater within-person RT variability in older
adults (ages 54-94 years) compared to younger adults (ages 17-36
years) using simple, choice, and lexical and semantic decision tasks.
Importantly, these results remained even when group differences in
response speed were statistically controlled.
In addition, IIV appears to predict future cognitive decline in
asymptomatic elders (Bielak, Hultsch, Strauss, Macdonald, & Hunter,
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2010a, 2010b; Lovden, Li, Shing, & Lindenberger, 2007; MacDonald,
Hultsch, & Dixon, 2003; Sugarman et al., 2014). For example,
increased IIV in simple, choice, and switching RT tasks among healthy
elders was associated with a greater likelihood of being classified with
greater cognitive impairment five years later (Bielak et al., 2010a). IIV
in various RT tasks has also discriminated cognitively intact elders
from symptomatic individuals, including those with MCI (Christensen
et al., 2005; Dixon et al., 2007) and AD (Duchek et al., 2009;
Tractenberg & Pietrzak, 2011). RT IIV also differentiated individuals
with mild MCI compared to moderate MCI, and has been shown to be a
better predictor of cognitive status than mean RT speed (Dixon et al.,
2007).
To date, few studies have examined the relationship between
estimates of IIV and the presence/absence of the APOE-ε4 allele in
asymptomatic elders. Duchek et al. (2009) compared group
differences in healthy elders with and without the APOE-ε4 allele and
individuals with early stage AD on IIV measures derived from three
attention tasks (Stroop, Simon, task switching). No significant
differences in overall IIV measures were reported between the healthy
APOE-ε4 carrier and non-carrier groups, with the one exception being
an IIV measure derived from Stroop incongruent trials. In a more
recent study, Kalin et al. (2014) examined within- and across-domain
IIV in healthy elders with and without the APOE-ε4 allele, individuals
with MCI, and those diagnosed with AD. Measures spanning several
cognitive domains, including working memory, semantic memory, and
executive functioning were examined. There was no main effect across
domains for IIV in healthy controls, MCI, or AD. However, healthy
elders with the APOE-ε4 allele demonstrated significantly greater
within-domain IIV in tasks of executive functioning compared to
healthy elders without the allele, though the effect size was small (𝜂𝜂𝑝𝑝2

=0.035).

A growing body of research has demonstrated that individuals
with MCI or early AD show increased variability in motor performance
compared to healthy controls (Dodge, Mattek, Austin, Hayes, & Kaye,
2012; Verghese et al., 2008). For example, using passive infrared
sensors fixed on the ceiling of the homes of elderly participants,
Dodge, Mattek, Austin, Hayes, and Kaye (2012) reported that
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individuals with non-amnestic MCI were less likely than controls to
exhibit trajectories of stable walking speed variability. Longitudinal
studies have also demonstrated that increased IIV in motor functioning
predicts future cognitive decline in asymptomatic individuals (Bangert
& Balota, 2012; Verghese, Wang, Lipton, Holtzer, & Xue, 2007).
However, the impact of the APOE-ε4 allele on motor functioning in the
preclinical stage has not been previously reported.
The purpose of the current investigation was to examine the
influence of the APOE-ε4 allele on the performance of asymptomatic
healthy elders in comparison to individuals with amnestic MCI (aMCI)
on a fine motor synchronization, paced finger-tapping task (PFTT). A
similar task has already been shown to discriminate individuals with
early AD compared to healthy controls (Bangert & Balota, 2012).
There were three specific objectives: (1) to compare mean inter-tap
interval (ITI) performance on the PFTT across three groups of elders
(cognitively intact APOE-ε4 non-carriers, cognitively intact APOE-ε4
carriers, and individuals with aMCI); (2) to compare PFTT IIV, defined
by the standard deviation of the ITI, across the three groups; (3) to
examine the association of mean and IIV scores from the PFTT with
scores from the Rey Auditory Verbal Learning Test (RAVLT; Rey,
1958), an episodic memory measure of list learning.
We predicted that IIV on the PFTT would distinguish between
the three groups. Specifically, we predicted that the aMCI group would
show greater IIV than the healthy asymptomatic groups, and the
cognitively intact APOE-ε4 carriers would show higher IIV than APOEε4 non-carriers. Further, we expected an inverse relationship (more
variability associated with lower memory scores) between episodic
memory performance on the RAVLT and IIV on the PFTT.

Method
Participants
Cognitively intact individuals (n = 106) were recruited via
newspaper advertisements placed in the greater Milwaukee area.
Healthy participants were subsequently classified into two groups:
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four aMCI participants (9 APOE-ε4 negative; 15 APOE-ε4 positive)
were also recruited from the Memory Disorders Clinic at the Medical
College of Wisconsin (MCW). All participants completed a cognitive
screening battery consisting of the Mini-Mental State Examination
(MMSE; Folstein, Folstein, & McHugh, 1975) and Mattis Dementia
Rating Scale-2 (DRS-2; Jurica, Leitten, & Mattis, 2001). The Lawton
Instrumental Activities of Daily Living (IADL) Scale (Lawton & Brody,
1969) and Geriatric Depression Scale (GDS; Yesavage et al., 1982)
were also administered at study entry.
Cognitively intact participants obtained a minimum score of 27
on the MMSE and performed within 1.5 standard deviations of ageappropriate means on the DRS-2 (total score) based on normative
data from the test manual (Jurica et al., 2001). aMCI participants met
diagnostic criteria based on Petersen’s criteria (Petersen, 2004) and
were evaluated by a neurologist with expertise in dementia to rule out
other possible bases for the memory impairment. All aMCI participants
obtained scores greater than or equal to 23 on the MMSE, scored
greater than 1.5 standard deviations below age-appropriate means on
the DRS-2 (total score), and below 4 on the modified Hachinski
Ischemic Scale. All participants obtained a minimum score of 4 (5point scale) on the IADL scale to rule out limitations in activities of
daily living, and all participants scored less than 14 on the GDS to rule
out moderate to severe depressive symptoms.
Participants acknowledged no history of neurologic disease or
other major medical illness and did not meet criteria for any Axis I
psychiatric illness or substance abuse/dependence according to the
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
(DSMIV). All participants were right-handed based on the Edinburgh
Handedness Inventory (Oldfield, 1971). Informed consent was
obtained in accordance with the Declaration of Helsinki and
institutional guidelines established by the MCW Human Subjects
Review Committee. All participants received financial compensation.

Genotyping
Genotyping for the APOE-ε4 alleles (ε2, ε3, ε4) was determined
using a polymerase chain reaction method described by Saunders et
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al. (1996) . Deoxyribonucleic acid was isolated with the Gentra
Systems Autopure LS for Large Sample Nucleic Acid Purification
(O'Brien, Campbell, Morken, Bair, & Heath, 2001). The APOE-ε4
negative group included participants with ε23 (n = 10) or ε33 (n = 55)
genotype; the APOE-ε4 positive group included participants with ε24
(n = 2), ε34 (n = 37), or ε44 (n = 2) genotype. The APOE genotyping
distribution for MCI participants was: ε23 (n = 1), ε33 (n = 8), ε24 (n
= 1), ε34 (n = 10) and ε44 (n = 4).

Measures
Episodic Memory
All participants completed the RAVLT, a commonly used episodic
memory measure. The RAVLT requires individuals to learn a list of 15
words over five trials. After an interference trial, individuals complete
an immediate recall trial, followed by a delayed recall trial 30 minutes
later. Mean scores were analyzed for total number of words recalled
across trials 1-5, immediate recall, and delayed recall.

Paced Finger-Tapping Task
All participants completed the PFTT while lying in a magnetic
resonance imaging (MRI) scanner. Participants were instructed to tap a
button box with their right index finger in synchrony with a visual
flashing yellow and black checkerboard presented at a stimulus
frequency of 3 Hertz. The PFTT was performed in a block design
paradigm. Eight blocks of finger tapping alternated with periods of
rest, during which participants viewed a black fixation cross in the
center of a white background. Tapping blocks and periods of rest were
each 12 seconds in duration. Based on the stimulus presentation
frequency of 3 Hertz, a perfect synchronization score consisted of 36
finger-taps per block for a total of 288 finger-taps with a mean intertap interval (ITI) of 333 milliseconds (ms) over the course of the task.
ITIs, measured in ms, were recorded using E-Prime software
(Psychology Software Tools, Pittsburgh, PA). it is three standard
deviations above or below each participant’s individual mean ITI score
were considered outliers and were removed prior to data analysis.
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Data Analyses
PFTT measures include mean ITI performance based on a
difference score from the target synchronization ITI of 333 ms (M-ITI)
and a measure of IIV based on the within-subject standard deviation
of ITIs (SD-ITI). Initial inspection of PFTT data using quantile-quantile
(QQ) plots and tests of normality (i.e., skewness and kurtosis;
Shapiro-Wilk statistic) revealed that PFTT indices (M-ITI and SD-ITI)
were not normally distributed. Therefore, a reciprocal square root data
transformation was performed on these measures to correct for
normality violations.
Group comparisons of demographics and cognitive screening
measures (MMSE and DRS-2), RAVLT, and PFTT were applied using
analyses of variance (ANOVAs), except for sex distribution, which was
analyzed using a Pearson chi-square test. ANOVA post hoc tests
include the Hochberg’s GT2 and Games-Howell corrections for
homogeneity and heterogeneity of variance respectively, as well as
unequal sample sizes.
Preliminary data analyses between demographic variables and
behavioral measures indicated significant negative correlations (range
of r = -0.18 to -0.35; p’s < 0.05) between age and mean performance
on the MMSE, RAVLT, and select DRS-2 indices. Age was also
positively correlated with SD ITI on the PFTT (r = 0.17; p = 0.05), and
education was positively correlated with the DRS-2 conceptualization
subscale (r = 0.24; p = 0.007) and DRS-2 total score (r = 0.17; p =
0.048).
Taking these findings into account, ANOVAs for the MMSE, DRS2 initiation/perseveration subscale, RAVLT trials 1-5, RAVLT immediate
recall, RAVLT delayed recall, and SD-ITI were performed using
standardized residual scores based on regression analyses with age as
a predictor. ANOVAs for the DRS-2 conceptualization subscale and
DRS-2 total score were performed using standardized residual scores
based on regression analyses with age and education as predictors.
Partial correlations, with age as a covariate, were conducted to
examine the association between RAVLT and PFTT performances
across groups.
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The aMCI group consisted of 24 participants (9 APOE-ε4
negative and 15 APOE-ε4 positive). Preliminary t-test analyses
between APOE-ε4 carriers and non-carriers within the aMCI group
indicated no differences in age, education, episodic memory
performance, or PFTT performance (p’s > 0.05). Therefore, the effect
of the APOE-ε4 allele was not further analyzed within the aMCI group.
Rather, individuals with aMCI were considered as a distinct group of
participants with substantiated cognitive status beyond a prodromal
stage of impairment based on diagnostic criteria (Petersen, 2004) and
results of cognitive screening measures (i.e., MMSE, DRS-2).

Results
Demographics
Group demographic statistics are shown in Table 1. There were
no significant group differences in age, education, or sex distribution
between groups (p’s > 0.05).

Cognitive Screening Battery
Table 1 shows significant omnibus group differences in mean
performance on the MMSE and DRS subscales for the three groups. As
expected, post-hoc analyses revealed that aMCI participants had
significantly lower scores on the MMSE and most DRS-2 subscales (p’s
< 0.05), but there were no significant differences between the APOEε4 negative and positive groups (p’s > 0.05) on these measures.

Episodic Memory Performance
Group comparisons of RAVLT episodic memory performance are
shown in Table 1. Significant group differences emerged for all RAVLT
measures with large effect sizes: trials 1-5 [F(2, 127) = 38.24, p <
0.001, 𝜂𝜂𝑝𝑝2 = 0.376], immediate recall [F(2, 127) = 39.65, p < 0.001,

𝜂𝜂𝑝𝑝2 = 0.384], and delayed recall [F(2, 127) = 52.06, p < 0.001, 𝜂𝜂𝑝𝑝2 =
0.451]. The aMCI group had significantly lower performance on all
three RAVLT measures compared to APOE-ε4 negative and positive
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groups (p’s < 0.001). In addition, post-hoc analyses revealed that the
APOE-ε4 positive group had significantly lower scores on RAVLT recall
measures compared to the APOE-ε4 negative group with medium
effect sizes: immediate recall (p = 0.007; d = 0.63); delayed recall (p
= 0.047; d = 0.49).

Paced Finger-Tapping Task Performance
Group comparisons of PFTT performance are shown in Table 1
and depicted in Figure 1. As predicted, significant group differences in
IIV (SD-ITI) emerged [F(2, 127) = 3.66, p = 0.029, ηp
2 = 0.054], despite equal mean level performance (M-ITI) [F(2, 127)
= 0.93, p = 0.399, 𝜂𝜂𝑝𝑝2 = 0.014]. Post-hoc analyses revealed that aMCI
participants had significantly greater IIV on the PFTT compared to the
APOE-ε4 negative group (p = 0.030, d = 0.67), and a marginally
significant greater IIV score compared to the APOE-ε4 positive group
(p = 0.069, d = 0.72). Effects sizes are in the medium range for both
comparisons, and the relatively small sample size of the APOE-ε4
positive group most likely explains the attenuated group difference
between the MCI group and the APOE-ε4 positive group. However,
there were no group differences in IIV between APOE-ε4 negative and
positive groups in post-hoc analyses (p = 0.997, d = 0.07).
Nonparametric analyses using Kruskal-Wallis tests and follow-up
Mann-Whitney tests (not shown) yielded similar results.
(Place Table 1 here)
(Place Figure 1 here)

Correlational Analyses
Results of partial correlational analyses (age as a covariate) between
PFTT and RAVLT measures across groups are shown in Table 2. As
predicted, significant negative relationships emerged between SD-ITI
and all three RAVLT measures: trials 1-5 (r = -0.207; p = 0.019),
immediate recall (r = -0.220; p = 0.012), and delayed recall (r = 0.209; p = 0.017). Increased IIV was associated with lower memory
scores. In contrast, PFTT mean level performance (MITI) was
significantly correlated only with RAVLT immediate recall (r = 0.205; p
= 0.020). Partial correlations between PFTT and RAVLT measures were
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also examined for each group separately (not shown). Within the aMCI
group, significant negative relationships emerged between SD-ITI and
RAVLT trials 1-5 (r = -0.545; p = 0.007) and delayed recall (r = 0.485; p = 0.019). Increased variability was associated with lower
memory scores. In contrast, no significant correlations emerged
between PFTT and RAVLT measures for the APOE-ε4 positive or APOEε4 negative groups.
(Place Table 2 here)

Discussion
The purpose of this study was to examine the performance of
healthy elders with and without the APOE-ε4 allele and an aMCI group
on a measure of motor performance, the PFTT. We were particularly
interested in the potential differences on a measure of IIV in
distinguishing between the three groups. In the context of similar
mean ITI accuracy across groups, we found motor timing IIV to be
greater for the aMCI group compared to both groups of cognitively
intact elders. However, we found no significant group differences
between asymptomatic APOE-ε4 non-carriers and carriers in motor
timing ITI mean accuracy or IIV. We also found that poorer
performance on RAVLT indices was associated with higher IIV,
particularly in the aMCI group.
As expected, the aMCI group demonstrated significantly poorer
neuropsychological test performance compared to cognitively intact
groups (APOE-ε4 carriers and non-carriers) on all RAVLT measures
(Petersen et al., 1999). We also found that cognitively intact APOE-ε4
carriers had significantly poorer performance on RAVLT indices than
non-carriers, consistent with research showing poorer episodic
memory performance during this clinically asymptomatic stage (El Haj
et al., 2016; Twamley, Ropacki, & Bondi, 2006).
The results reported here are consistent with several recent
studies showing that increased IIV in performance on a variety of fine
and gross motor tasks (i.e., finger tapping, walking speed, etc.) may
constitute a useful cognitive marker for the transition from cognitively
intact to the prodromal aMCI stage (Buracchio, Dodge, Howieson,
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Wasserman, & Kaye, 2010; Dodge et al., 2012; Verghese et al.,
2007). Further, these findings emerged in the context of equivalent
mean level motor timing performance across groups, which suggests
that IIV indices may provide valuable information above and beyond
traditional measures of cognitive performance based on mean scores
(Hultsch, MacDonald, Hunter, Levy-Bencheton, & Strauss, 2000).
Reliance on the standard approach of comparing mean level
performance between groups would not have detected differences in
motor timing variability at the prodromal aMCI stage in our sample.
Post-hoc analyses revealed that aMCI participants had
significantly greater IIV on the PFTT compared to APOE-ε4 non-carriers
and a marginally significant greater IIV score compared to APOE-ε4
carriers; however, effect sizes are in the medium range for both
comparisons with a slightly stronger effect for the latter comparison.
The relatively small sample size of the APOE-ε4 positive group most
likely explains this attenuated group difference.
Consistent with previous studies, we found no significant
differences in performance variability on the PFTT between cognitively
intact APOE-ε4 carriers and non-carriers. Duchek et al. (2009) also did
not find significant differences in IIV between healthy APOE-ε4 carriers
and non-carriers using three different selective attention tasks, except
for a single score on incongruent trials of the Stroop task. Kalin et al.
(2014) reported a very small effect size difference between healthy
elders with the APOE-ε4 allele compared to those without the allele for
within-domain IIV in tasks of executive functioning. Nevertheless,
longitudinal data is necessary to more clearly determine the predictive
value of IIV for progression to the MCI stage and dementia.
It is important to note that, while the aMCI group exhibited
significantly greater motor timing IIV compared to cognitively intact
elders, the magnitude of this difference was relatively small compared
to the large effect sizes that emerged for the same group comparisons
of episodic memory performances. Further, in contrast with episodic
memory performance, which was able to distinguish between healthy
APOE-ε4 carriers and non-carriers, IIV on the PFTT was equal for both
groups of cognitively intact elders. This suggests that episodic memory
performance, in comparison to motor timing IIV, continues to serve as
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the most reliable predictor of cognitive decline during the
asymptomatic preclinical stage of AD.
Age-related differences in IIV may be most apparent on
speeded tasks that place increased demands on executive functioning
or working memory (Dixon et al., 2007), or other cognitively complex
tasks (Hultsch et al., 2000; Strauss, Bielak, Bunce, Hunter, & Hultsch,
2007). It is possible that IIV on the PFTT did not recruit sufficiently
complex executive function and attentional control mechanisms to
elicit strong IIV differences between cognitively intact APOE-ε4 carriers
and non-carriers. For example, it may be necessary to employ tasks
that have stronger working memory demands. In contrast, MCI is
characterized by attentional lapses, failures of inhibition, and reduced
executive control, all of which can serve as mechanisms for increased
IIV.
Viewed from a neurological perspective, there may be particular
brain regions that are important in maintaining low response
variability. Recent neuroimaging studies indicate that increased IIV is
associated with neurophysiological deterioration within frontal
systems, particularly in white matter. For example, Bunce et al. (2007)
found that white matter hyperintensities were significantly correlated
with IIV on speeded cognitive tasks in healthy older adults (ages 6064). Importantly, this relationship was unique to white matter integrity
in the frontal lobes, demonstrating that these neural pathways play a
key role in increased IIV. Functional MRI studies have also shown
important relationships between the frontal lobes and increased IIV
(Bellgrove, Hester, & Garavan, 2004). Further, alterations in select
neurotransmitters, such as neuromodulatory deficiencies in dopamine,
may underscore increased IIV in cognitive performance (Hultsch et al.,
2002; Li, Lindenberger, & Sikstrom, 2001; Rabbitt, Osman, Moore, &
Stollery, 2001). While subtle alterations within frontal systems may be
detectable via imaging techniques, our results suggest that these
changes are not yet apparent through behavioral measures of IIV in
either APOE-ε4 carrier or non-carrier asymptomatic individuals.
There are limitations that may have obscured the potential IIV
differences in comparison of the APOE-ε4 carriers and non-carriers
prior to symptom onset. First, we employed only a single measure of
Journal of Clinical and Experimental Neuropsychology, Vol 39, No. 9 (2017): pg. 866-875. DOI. This article is © Taylor &
Francis (Routledge) and permission has been granted for this version to appear in e-Publications@Marquette. Taylor &
Francis (Routledge) does not grant permission for this article to be further copied/distributed or hosted elsewhere
without the express permission from Taylor & Francis (Routledge).

13

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

motor timing IIV (fine motor synchronization) to an external stimulus.
Additional measures of motor timing and other indices of motor
movement may provide a more nuanced assessment of motor
variability. A broad motor performance battery including fine, gross,
and complex tasks, in addition to measures of gait and ambulation,
may prove useful in eliciting differences in asymptomatic elders with
different genetic risk factors.
Further, the PFTT may not have recruited sufficient cognitive
complexity to distinguish between APOE-ε4 carriers and non-carriers.
Assuming IIV is a frontally mediated process, as has been suggested
(i.e., Bellgrove et al., 2004), then more complex executive tasks may
prove better able to distinguish those at risk for AD. Specifically, tasks
that tap aspects of attentional selection, inhibition, and switching may
be considered for future studies, as such tasks appear to be
particularly sensitive to MCI and early AD (Castel, Balota, Hutchison,
Logan, & Yap, 2007; Spieler, Balota, & Faust, 1996).
Ultimately, a longitudinal design is necessary to provide more
definitive statements about the predictive utility of increased IIV in
individuals with genetic susceptibility to AD. With regard to sampling
procedures, cognitively intact study participants were volunteers living
independently in the local community and were highly educated,
mostly Caucasian (98.5%), and predominantly female (70.5%). These
factors limit the generalizability of our findings, and future
investigations would benefit from inclusion of a more heterogeneous
sample.

Conclusions
Overall, findings from this study suggest that increased IIV on a
fine motor synchronization task is evident at the aMCI stage, but IIV
differences did not distinguish between APOE-ε4 allele carriers and
non-carriers during the preclinical stage. Further, motor timing IIV
appears to have weaker capacity to distinguish between individuals at
AD risk compared to episodic memory performance, a well-established
predictor of cognitive decline. More definitive findings from longitudinal
studies and the investigation of a broader repertoire of motor functions

Journal of Clinical and Experimental Neuropsychology, Vol 39, No. 9 (2017): pg. 866-875. DOI. This article is © Taylor &
Francis (Routledge) and permission has been granted for this version to appear in e-Publications@Marquette. Taylor &
Francis (Routledge) does not grant permission for this article to be further copied/distributed or hosted elsewhere
without the express permission from Taylor & Francis (Routledge).

14

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

are needed to determine the value of IIV measurement in predicting
cognitive decline in asymptomatic elders.
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Table 1. Demographics and Cognitive Screening, Episodic Memory, and
Paced Finger-Tapping Performances by Group

Note. ε4 = apolipoprotein E-epsilon 4; MCI = mild cognitive impairment;
MMSE = Mini-Mental State Examination; DRS-2 = Dementia Rating Scale-2nd
Edition; RAVLT = Rey Auditory Verbal Learning Test; ms = milliseconds; ITI =
inter-tap interval. ^9 ε4–, 15 ε4+. aPearson Chi-Square Test. bCramer’s V .
c
ANOVA results using standardized residual scores based on regression with
age as a predictor. dANOVA results using standardized residual scores based
on regression with age and education as predictors.
Table 2. Pearson Correlationsa between Paced Finger-Tapping and Episodic
Memory Test Performances across Groups

Note. RAVLT = Rey Auditory Verbal Learning Test; M-ITI = mean inter-tap
interval; SD-ITI = standard deviation of inter-tap interval. aPartial correlations
(covariate: age). * p < .05.
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Figure Legend
Figure 1. Paced finger-tapping performance by group. Left panel presents
mean accuracy, represented by mean inter-tap interval (ITI) minus the target
ITI (333 milliseconds). Right panel presents mean standard deviation of the
ITI, a measure of intraindividual variability. Error bars represent standard
error of the mean. ε4 = apolipoprotein E-epsilon 4; MCI = mild cognitive
impairment; ITI = inter-tap interval.
* p < .05.
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